Printer Friendly

Alibaba Group partners with Macau SAR Government for Macau's digital transformation.

M2 EQUITYBITES-August 4, 2017-Alibaba Group partners with Macau SAR Government for Macau's digital transformation

(C)2017 M2 COMMUNICATIONS http://www.m2.com

Alibaba Group (NYSE:BABA), a large online and mobile marketplace, announced on Thursday that it and the Government of Macau Special Administrative Region (Macau), have entered into a strategic partnership framework agreement, under which Alibaba will support Macau's transformation into a smart city.

This transformation will take place by using cloud computing technologies in order to bring benefits to both residents and tourists visiting the city.

This partnership, financial details of which were not available, is for four years.

Reportedly, by leveraging the advanced technologies provided by Alibaba Cloud, the cloud computing arm of Alibaba Group, the parties will collaborate in upgrading the IT infrastructure in Macau to foster developments in tourism, transportation, healthcare, governance and talent development.

According to the company, in the first phase from 2017 to 2019, the collaboration will focus on cloud computing, smart transportation, smart tourism, smart healthcare, and smart city governance, as well as talent development.

Alibaba Cloud provides a comprehensive suite of cloud computing services to businesses worldwide, including merchants doing business on Alibaba Group marketplaces, start-ups, corporations and government organisations.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2017 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Geographic Code:9MACA
Date:Aug 4, 2017
Words:211
Previous Article:Nexus awarded US FDA for Isoproterenol Hydrochloride Injection ANDA for heart block.
Next Article:Jazz Pharmaceuticals wins US FDA approval for Vyxeos for acute myeloid leukemia.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters